We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
2401
Ocular Therapeutix
OCUL
$2.22B
$47K ﹤0.01%
16,685
+9,592
+135% +$31.8K
PAYO icon
2402
Payoneer
PAYO
$2.42B
$47K ﹤0.01%
8,467
-25,902
-75% -$163K
STR
2403
DELISTED
Sitio Royalties
STR
$47K ﹤0.01%
1,615
-2,750
-63% -$79.6K
TARK icon
2404
Tradr 2X Long Innovation ETF
TARK
$16.9M
$47K ﹤0.01%
2,280
+539
+31% +$15.7K
CMRX
2405
DELISTED
Chimerix, Inc.
CMRX
$47K ﹤0.01%
25,274
+18,682
+283% +$36.6K
SPWR
2406
DELISTED
SunPower Corporation Common Stock
SPWR
$47K ﹤0.01%
2,606
-26,982
-91% -$553K
FRG
2407
DELISTED
Franchise Group, Inc.
FRG
$47K ﹤0.01%
1,966
-2,281
-54% -$59.5K
ASX icon
2408
ASE Group
ASX
$103B
$46K ﹤0.01%
7,382
-14,331
-66% -$84K
IPSC icon
2409
Century Therapeutics
IPSC
$349M
$46K ﹤0.01%
8,952
+4,795
+115% +$45.3K
MGV icon
2410
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.7B
$46K ﹤0.01%
446
+208
+87% +$20.9K
KG
2411
Kestrel Group
KG
$60.5M
$46K ﹤0.01%
1,096
+15
+1% +$639
NGD
2412
DELISTED
New Gold Inc
NGD
$46K ﹤0.01%
46,059
-456,060
-91% -$459K
NRDS icon
2413
NerdWallet
NRDS
$639M
$46K ﹤0.01%
4,749
+2,470
+108% +$27.7K
PJT icon
2414
PJT Partners
PJT
$4.57B
$46K ﹤0.01%
626
-907
-59% -$68K
PMT
2415
PennyMac Mortgage Investment
PMT
$828M
$46K ﹤0.01%
3,689
-2,670
-42% -$36.3K
RDI icon
2416
Reading International Class A
RDI
$33.2M
$46K ﹤0.01%
16,640
-365
-2% -$1.17K
RLX icon
2417
RLX Technology
RLX
$2.44B
$46K ﹤0.01%
19,723
-38,483
-66% -$68.3K
RVMD icon
2418
Revolution Medicines
RVMD
$43.3B
$46K ﹤0.01%
1,937
-4,014
-67% -$85.3K
SRTS icon
2419
Sensus Healthcare
SRTS
$52M
$46K ﹤0.01%
6,187
-5,165
-45% -$46.6K
INVX
2420
Innovex International
INVX
$2.15B
$46K ﹤0.01%
1,687
-370
-18% -$8.82K
ITCI
2421
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$46K ﹤0.01%
861
-5,402
-86% -$271K
GTHX
2422
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$46K ﹤0.01%
8,328
-9,076
-52% -$76.1K
AGIO icon
2423
Agios Pharmaceuticals
AGIO
$2B
$45K ﹤0.01%
1,614
-13,246
-89% -$373K
ARDX icon
2424
Ardelyx
ARDX
$1.01B
$45K ﹤0.01%
15,827
-29,317
-65% -$49.6K
ATHM icon
2425
Autohome
ATHM
$2.6B
$45K ﹤0.01%
1,472
-2,673
-64% -$79.5K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.